Literature DB >> 25004350

Obesity and age at diagnosis of endometrial cancer.

Nicole S Nevadunsky1, Anne Van Arsdale, Howard D Strickler, Alyson Moadel, Gurpreet Kaur, Joshua Levitt, Eugenia Girda, Mendel Goldfinger, Gary L Goldberg, Mark H Einstein.   

Abstract

OBJECTIVE: Obesity is an established risk factor for development of endometrial cancer. We hypothesized that obesity might also be associated with an earlier age at endometrial cancer diagnosis, because mechanisms that drive the obesity-endometrial cancer association might also accelerate tumorigenesis.
METHODS: A retrospective chart review was conducted of all cases of endometrial cancer diagnosed from 1999 to 2009 at a large medical center in New York City. The association of body mass index (BMI) with age at endometrial cancer diagnosis, comorbidities, stage, grade, and radiation treatment was examined using analysis of variance and linear regression. Overall survival by BMI category was assessed using Kaplan-Meier method and the log-rank test.
RESULTS: A total of 985 cases of endometrial cancer were identified. The mean age at endometrial cancer diagnosis was 67.1 years (±11.9 standard deviation) in women with a normal BMI, whereas it was 56.3 years (±10.3 standard deviation) in women with a BMI greater than 50. Age at diagnosis of endometrioid-type cancer decreased linearly with increasing BMI (y=67.89-1.86x, R=0.049, P<.001). This association persisted after multivariable adjustment (R=0.181, P<.02). A linear association between BMI and age of nonendometrioid cancers was not found (P=.12). There were no differences in overall survival by BMI category.
CONCLUSIONS: Obesity is associated with earlier age at diagnosis of endometrioid-type endometrial cancers. Similar associations were not, however, observed with nonendometrioid cancers, consistent with different pathways of tumorigenesis. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2014        PMID: 25004350     DOI: 10.1097/AOG.0000000000000381

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  27 in total

Review 1.  Molecular cues on obesity signals, tumor markers and endometrial cancer.

Authors:  Danielle Daley-Brown; Gabriela M Oprea-Ilies; Regina Lee; Roland Pattillo; Ruben R Gonzalez-Perez
Journal:  Horm Mol Biol Clin Investig       Date:  2015-01

2.  A nationwide population-based retrospective cohort study of the risk of uterine, ovarian and breast cancer in women with polycystic ovary syndrome.

Authors:  Cheng-Che Shen; Albert C Yang; Jeng-Hsiu Hung; Li-Yu Hu; Shih-Jen Tsai
Journal:  Oncologist       Date:  2014-11-19

3.  Prospective evaluation of abnormal glucose metabolism and insulin resistance in patients with atypical endometrial hyperplasia and endometrial cancer.

Authors:  Akira Mitsuhashi; Takashi Uehara; Shinsuke Hanawa; Makio Shozu
Journal:  Support Care Cancer       Date:  2016-12-27       Impact factor: 3.603

Review 4.  Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment.

Authors:  Seong Lin Teoh; Srijit Das
Journal:  Tumour Biol       Date:  2016-09-14

5.  Should we customize PTV expansions for BMI? Daily cone beam computerized tomography to assess organ motion in postoperative endometrial and cervical cancer patients.

Authors:  Arya Amini; Peter E DeWitt; Yevgeniy Vinogradskiy; Chad G Rusthoven; Cem Altunbas; Tracey E Schefter; Christine M Fisher
Journal:  Rep Pract Oncol Radiother       Date:  2016-03-02

6.  Endometrial Cancer Associated Symptoms: A Case-Control Study.

Authors:  Janelle B Pakish; Karen H Lu; Charlotte C Sun; Jennifer K Burzawa; Anthony Greisinger; Frances A Smith; Bryan Fellman; Diana L Urbauer; Pamela T Soliman
Journal:  J Womens Health (Larchmt)       Date:  2016-06-02       Impact factor: 2.681

7.  Lack of improvement in survival rates for women under 50 with endometrial cancer, 2000-2011.

Authors:  Ana M Rodriguez; Kathleen M Schmeler; Yong-Fang Kuo
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-15       Impact factor: 4.553

8.  Uterine Corpus Malignancies in Appalachia Kentucky: Incidence, Survival, and Related Health Disparities.

Authors:  Marian Symmes Johnson; Thomas C Tucker; Quan Chen; Bin Huang; Christopher P DeSimone; Rachel W Miller; Lauren A Baldwin; Tricia I Fredericks; Brian T Burgess; Frederick R Ueland
Journal:  South Med J       Date:  2020-01       Impact factor: 0.954

9.  Adipokines Deregulate Cellular Communication via Epigenetic Repression of Gap Junction Loci in Obese Endometrial Cancer.

Authors:  Srikanth R Polusani; Yi-Wen Huang; Guangcun Huang; Chun-Wei Chen; Chiou-Miin Wang; Li-Ling Lin; Pawel Osmulski; Nicholas D Lucio; Lu Liu; Ya-Ting Hsu; Yufan Zhou; Chun-Lin Lin; Irene Aguilera-Barrantes; Philip T Valente; Edward R Kost; Chun-Liang Chen; Eun Yong Shim; Sang Eun Lee; Jianhua Ruan; Maria E Gaczynska; Pearlly Yan; Paul J Goodfellow; David G Mutch; Victor X Jin; Bruce J Nicholson; Tim H-M Huang; Nameer B Kirma
Journal:  Cancer Res       Date:  2018-11-02       Impact factor: 12.701

10.  Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer.

Authors:  Melinda S Yates; Adriana M Coletta; Qian Zhang; Rosemarie E Schmandt; Meena Medepalli; Denise Nebgen; Beth Soletsky; Andrea Milbourne; Erma Levy; Bryan Fellman; Diana Urbauer; Ying Yuan; Russell R Broaddus; Karen Basen-Engquist; Karen Lu
Journal:  Cancer Prev Res (Phila)       Date:  2018-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.